Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia | Zendy

Lloyd Mulenga | Zendy; Patrick Musonda | Zendy; Albert Mwango | Zendy; Michael J. Vinikoor | Zendy; MaryAnn Davies | Zendy; Aggrey Mweemba | Zendy; Alexandra Calmy | Zendy; Jeffrey S. A. Stringer | Zendy; Olivia Keiser | Zendy; H. Benjamin | Zendy; Gilles Wandeler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia

Author(s) -

Lloyd Mulenga,

Patrick Musonda,

Albert Mwango,

Michael J. Vinikoor,

MaryAnn Davies,

Aggrey Mweemba,

Alexandra Calmy,

Jeffrey S. A. Stringer,

Olivia Keiser,

H. Benjamin,

Gilles Wandeler

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu117

Subject(s) - medicine , renal function , odds ratio , kidney disease , regimen , confidence interval , creatinine , incidence (geometry) , urology , optics , physics

Although tenofovir disoproxil fumarate (TDF) use has increased as part of first-line antiretroviral therapy (ART) across sub-Saharan Africa, renal outcomes among patients receiving TDF remain poorly understood. We assessed changes in renal function and mortality in patients starting TDF- or non-TDF-containing ART in Lusaka, Zambia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research